Forecast to Publish a Funding Opportunity Announcement for Copy of Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24) (Clinical Trial Optional)
ID: 358821Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358821
Timeline
    Description

    The National Institutes of Health (NIH) is preparing to publish a Funding Opportunity Announcement for the renewal of the Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24), which is a cooperative agreement aimed at advancing research on alcohol use disorder (AUD). This initiative will support two collaborative research consortia focused on understanding the brain-body interactions that contribute to excessive alcohol consumption and AUD, encouraging innovative research methodologies and the use of advanced technologies. The estimated total program funding is $1,200,000, with two awards expected, and interested applicants are encouraged to begin forming collaborations in anticipation of the application process, which is expected to open in October 2025. For further inquiries, potential applicants can contact Mark Egli at Mark.Egli@nih.gov or by phone at 301-594-6382.

    Point(s) of Contact
    Mark Egli
    (301) 594-6382
    Mark.Egli@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Forecast to Publish a Funding Opportunity Announcement for Copy of Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24) (Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Funding Opportunity Announcement for the renewal of the Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24), with a focus on studying the brain-body dysregulation associated with excessive alcohol consumption and Alcohol Use Disorder (AUD). This initiative aims to support two collaborative research consortia through a competitive process, encouraging innovative research that examines the interactions between alcohol and various causal influences, while promoting the use of advanced tools and technologies to enhance understanding of brain function related to alcohol misuse. The estimated total program funding is $700,000, with two awards expected, and interested applicants are encouraged to begin forming collaborations in anticipation of the announcement, which is expected to be posted on October 1, 2025, with applications not currently being solicited. For further inquiries, potential applicants can contact Mark Egli at mark.egli@nih.gov or by phone at 301-594-6392.
    Forecast to Publish a Funding Opportunity Announcement for Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Funding Opportunity Announcement for the Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia, which will support collaborative research aimed at understanding the brain-body dysregulation associated with excessive alcohol consumption and Alcohol Use Disorder (AUD). This initiative seeks to foster hypothesis-driven research that explores the interactions between alcohol and various causal factors, with a focus on identifying translatable markers and mechanisms for prevention and intervention strategies. The estimated total program funding is $10 million, with approximately 16 awards expected, and interested applicants are encouraged to begin forming collaborations in anticipation of the announcement, which is expected to be posted in October 2025. For further inquiries, potential applicants can contact Mark Egli at mark.egli@nih.gov or by phone at (301) 594-6392.
    Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a limited competition grant for the continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource, with a focus on understanding the effects of adolescent alcohol use on brain development. This cooperative agreement aims to support research that follows participants aged 12 to 37 years to gather critical data on how early and late onset drinking impacts adult behavior and health outcomes. The findings from this initiative are expected to inform evidence-based alcohol prevention strategies and interventions, ultimately improving public health. The estimated total program funding is $350,000, with one award anticipated, and interested applicants can reach out to Shailesh Kumar at shailesh.kumar2@nih.gov or by phone at 301-827-0722 for further information. The synopsis is expected to be posted on September 1, 2025, with applications closing on August 1, 2026, and the project start date projected for July 1, 2027.
    Forecast to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Funding Opportunity Announcement for a limited competition aimed at the continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) research project sites. This initiative seeks to gather critical data on the effects of adolescent alcohol consumption on brain development and functioning, with a focus on understanding the long-term impacts of early versus late onset drinking behaviors. The funding, totaling approximately $5 million, will support up to seven awards under a cooperative agreement, with applications expected to be solicited starting May 2026, and the project anticipated to commence in July 2027. For further inquiries, interested parties can contact Dominique Lorang-Leins at Lorangd@mail.nih.gov or by phone at 301-594-6228.
    Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a limited competition grant for the continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource, with a focus on understanding the impact of adolescent alcohol use on brain development and behavior. This cooperative agreement aims to support research that follows participants up to 37 years of age, providing critical data to inform evidence-based alcohol prevention strategies and interventions. The estimated total program funding is $600,000, with one award expected to be made, and interested applicants are encouraged to prepare collaborations in advance, as applications are not currently being solicited. For further inquiries, potential applicants can contact Dominique Lorang-Leins at 301-594-6228 or via email at lorangd@mail.nih.gov, with key deadlines including an estimated synopsis post date of September 1, 2025, and an estimated award date of July 1, 2027.
    Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource (Collaborative U24 - Clinical Trials not allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource, aimed at investigating the long-term effects of adolescent alcohol exposure on brain-behavior relationships. This initiative seeks to support collaborative research across various institutions to elucidate the mechanisms behind persistent changes in brain maturation and adult outcomes due to adolescent drinking, ultimately contributing to improved treatment methods and prevention strategies for alcohol-related issues. The funding will be provided through a Cooperative Agreement, with an expected award date in May 2026, and interested small businesses are encouraged to begin forming collaborations in anticipation of the application process. For further inquiries, potential applicants can contact Dr. Mohammed Akbar at akbarm@mail.nih.gov or by phone at 301-443-6009.
    Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource (Collaborative U24 - Clinical Trials not allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource, which will be structured as a Cooperative Agreement. This initiative aims to solicit research applications that investigate the mechanisms of persistent changes in brain-behavior relationships following adolescent alcohol exposure, with a focus on enhancing treatment methods and prevention strategies for alcohol-related issues. The funding opportunity is particularly relevant for small businesses with expertise in molecular insights and collaborative investigations, as it seeks to establish a foundational knowledge base across various research fields. Interested applicants should note that applications are not currently being solicited, but they can prepare for submission as the estimated synopsis will be posted on July 30, 2025, with a closing date of September 30, 2025, and an anticipated award date of May 30, 2026. For further inquiries, potential applicants can contact Dr. Mohammed Akbar at akbarm@mail.nih.gov or by phone at 301-443-6009.
    Notice of Intent to Publish a Funding Opportunity Announcement for Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (R41/R42 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at supporting the development of medications for Alcohol Use Disorder (AUD) and Alcohol-Associated Organ Damage (AAOD) through the Investigational New Drug (IND)-enabling and early-stage development process. Eligible applicants, specifically small businesses, are invited to propose projects that advance therapeutic candidates with a solid foundation of background data, facilitating their transition to preclinical and clinical phases of development. This initiative is crucial for addressing the public health challenges associated with alcohol-related conditions, with the NOFO expected to be published on January 16, 2025, and applications due by April 5, 2025. The funding will utilize R41/R42 activity codes, and the estimated award date is September 30, 2025, with project start dates anticipated for December 1, 2025.
    Notice of Intent to Publish a Funding Opportunity Announcement for Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (R43/R44 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at supporting the development of medications for Alcohol Use Disorder (AUD) and alcohol-associated organ damage through the Investigational New Drug (IND)-enabling and early-stage development phases. This funding opportunity is specifically targeted at small businesses that can propose innovative therapeutic agents, with a requirement for applicants to present a therapeutic candidate backed by substantial preliminary data demonstrating its viability for clinical application. The initiative is crucial for advancing potential treatments closer to U.S. Food and Drug Administration (FDA) approval, with the NOFO expected to be published on January 16, 2025, and applications due by April 5, 2025. The estimated award date is September 30, 2025, and projects may begin as early as December 1, 2025, with encouragement for women-owned and socially or economically disadvantaged businesses to apply.
    Alcohol Health Services Research (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a funding opportunity titled "Alcohol Health Services Research (R01 Clinical Trial Optional)" aimed at addressing the treatment gap for individuals with Alcohol Use Disorder (AUD). This initiative focuses on five key areas: increasing access to treatment, enhancing the appeal of treatment options, analyzing cost structures and insurance systems, studying the dissemination of evidence-based practices, and reducing health disparities among affected populations. The program encourages innovative research designs and participation from diverse organizations, with a maximum budget of $500,000 available for direct costs over a five-year project period. Interested applicants can submit proposals starting January 5, 2025, and should direct inquiries to grantsinfo@nih.gov for further information.